A study described by the Subburayan and their colleagues found that human glioma cells treated with thymoquinone showed inhibition in cell growth via inducing Par‐4 expression, which triggers cellular senescence and prostate apoptosis response‐4 (Par‐4) tumor suppressor protein expressions. This evidence concerns the gene TCHP and central nervous system cancer.